Robert Harrington to Drug-Eluting Stents
This is a "connection" page, showing publications Robert Harrington has written about Drug-Eluting Stents.
Connection Strength
1.173
-
Selecting revascularization strategies in patients with coronary disease. N Engl J Med. 2015 Mar 26; 372(13):1261-3.
Score: 0.472
-
Calculating risks and benefits to help guide revascularization decisions: turning all available data into useful information. J Am Coll Cardiol. 2014 Aug 05; 64(5):433-5.
Score: 0.452
-
Usefulness and safety of vorapaxar in patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention (from the TRACER Trial). Am J Cardiol. 2014 Sep 01; 114(5):665-73.
Score: 0.112
-
Outcomes of second revascularization procedures after stent implantation. J Med Syst. 2008 Apr; 32(2):177-86.
Score: 0.073
-
Lack of Concordance Between Local Investigators, Angiographic Core Laboratory, and Clinical Event Committee in the Assessment of Stent Thrombosis: Results From the TRACER Angiographic Substudy. Circ Cardiovasc Interv. 2016 May; 9(5):e003114.
Score: 0.032
-
Impact of glycoprotein IIb/IIIa inhibitors on the efficacy and safety of ticagrelor compared with clopidogrel in patients with acute coronary syndromes: Analysis from the Platelet Inhibition and Patient Outcomes (PLATO) Trial. Am Heart J. 2016 Jul; 177:1-8.
Score: 0.032